FDA Inspection
Zhejiang Dingtai Pharmaceutical Co., LtdZhejiang Dingtai Pharmaceutical Co., Ltd – FDA Inspection, Jan 25, 2019
Record Details
This FDA Inspection record concerns Zhejiang Dingtai Pharmaceutical Co., Ltd, with an inspection on January 25, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Kara D. Dobbin (Issuing Officer)
View Company Profile
ID · 1cfbc8fa-d3de-4a2f-a555-273a28d053fe
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1084048
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Zhejiang Dingtai Pharmaceutical Co., Ltd
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 28, 2025 | Not classified | Office of Inspections and Investigations | |
| March 24, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Zhejiang Dingtai Pharmaceutical Co., Ltd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.